Healthcare Royalty, Inc. HCRX 深 滬
已收盤 07-30 16:00:00 美东时间
0.00
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 總市值 0
- 52周最高 0.00
- 市盈率 靜 0.00
- 換手率 0.00%
- 52周最低 0.00
- 委 比 0.00%
- 總股本 2.15亿
- 歷史最高 0.00
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 0.00
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
Nanobiotix reported key milestones in its third quarter 2025 update, including a $71 million non-dilutive royalty financing with HCRx, advancement of JNJ-1900 (NBTXR3) clinical development with esophageal cancer data and Phase 3 study transfer to J&J, and progress in the Curadigm Nanoprimer program. The company expects JNJ-1900 clinical updates in 2026 across melanoma, lung, pancreatic, and esophageal cancers. With €20.4 million in cash and the H...
2025-11-24 21:15
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
Nanobiotix has entered into a $71 million royalty-based financing agreement with HealthCare Royalty to extend its cash runway into early 2028. The funding supports development in head and neck cancer and lung cancer, and enables self-sustainability and growth of next-generation nanotherapeutic platforms. HealthCare Royalty will receive a capped portion of milestones and royalties on JNJ-1900 (NBTXR3). The upfront payment is $50 million, with an a...
2025-10-31 07:00
REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million
$150 million secured at closing extends cash runway into early 2027 REGENXBIO retains additional potential non-dilutive funding opportunities, including monetization of Priority Review Vouch...
2025-05-20 04:05
快讯 | HealthCare Royalty和Blue Owl宣布与tg therapeutics进行2.5亿美元的债务融资
Healthcare Royalty and Blue Owl Announce $250M Debt Financing With TG Therapeut...
2024-08-06 21:02
快讯 | opko健康和医疗专利权达成2.5亿美元的债券购买协议，由Ngenla的利润份额支付担保
OPKO Health and Healthcare Royalty Enter Into $250 Million Note Purchase Agreem...
2024-07-18 04:14
Spero治疗公司与医疗保健版税合作伙伴签署收入利息融资协议
Published: 09/30/2021SPRO Spero Therapeutics Inc (NASDAQ: SPRO) has entered int...
2021-09-30 19:00
美股前瞻丨突发！央视财经“点名”芯片！教育行业裁员潮惊动监管
基建法案可能导致美国预算赤字扩大2560亿美元；法巴资管二季度13F出炉：大幅增持普拉格能源；高盛上调标普500指数目标位，全年回报率料达25%>>
2021-08-06 20:18
美股IPO预告 | 7只新股来袭！亚马逊物流中心REIT领衔
上周美股新股中，ICVX首日收涨133%；哈啰单车宣布撤回赴美IPO申请；中美官方火速回应“SEC暂停中概股上市登记”传言 >>
2021-08-02 20:51
一周财经日历 | 贝莱德或打响13F第一枪！阿里中芯国际重磅财报来袭
中概股受多重因素影响接连下挫，关注贝莱德会否“撤离中概”；新东方、好未来突然取消下周业绩公布计划；彭博预期7月非农就业人口为93万人>>
2021-08-01 14:47
